Search research articles
Contact Us
Filters
Showing results (21-30 of 98) with videos related to
Page
of 10
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 30, 2025
How to treat primary cutaneous B cell lymphoma - Results from a monocentric cohort study on 98 patients
Rohat Cankaya, Pit Leonard Kleiner, Franz Joachim Hilke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 24, 2021
Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients
Oana D Persa, Kerstin Schatton, Albert Rübben, et al.
International Journal of Molecular Sciences
|
February 5, 2020
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Anja Wessely, Theresa Steeb, Michael Erdmann, et al.
Cardiovascular and Interventional Radiology
|
October 28, 2025
Initial Experience with Transarterial Chemoembolization in Metastatic Cutaneous Melanoma Patients with Hepatic Progression on Immune Checkpoint Inhibitors
Timo Alexander Auer, Max Schlaak, Gabor Dobos, et al.
Journal of Cancer Research and Clinical Oncology
|
February 10, 2020
Guidelines for uveal melanoma: a critical appraisal of systematically identified guidelines using the AGREE II and AGREE-REX instrument
Theresa Steeb, Kinan M Hayani, Paul Förster, et al.
European Radiology
|
November 29, 2019
Single-slice CT measurements allow for accurate assessment of sarcopenia and body composition
David Zopfs, Sebastian Theurich, Nils Große Hokamp, et al.
Cancers
|
July 9, 2022
Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
Dirk Tomsitz, Max Schlaak, Sarah Zierold, et al.
Langenbeck'S Archives of Surgery
|
January 21, 2023
Oligometastatic disease and visceral resections in advanced malignant melanoma: a propensity-matched analysis
Alexander Urbanski, Julia Minnemann, Cornelia Mauch, et al.
International Journal of Clinical and Experimental Medicine
|
January 8, 2013
(68)Ga-DotaTATE PET-CT followed by Peptide Receptor Radiotherapy in combination with capecitabine in two patients with Merkel Cell Carcinoma
Matthias C Schmidt, Klara Uhrhan, Birgid Markiefka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Multimodal approach predicts relapse upon cessation of immune checkpoint inhibitors in advanced melanoma
Ka-Won Noh, Yuri Tolkach, Doris Helbig, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 98) with videos related to
Sort By:
Page
of 10
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
May 30, 2025
How to treat primary cutaneous B cell lymphoma - Results from a monocentric cohort study on 98 patients
Rohat Cankaya, Pit Leonard Kleiner, Franz Joachim Hilke, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 24, 2021
Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients
Oana D Persa, Kerstin Schatton, Albert Rübben, et al.
International Journal of Molecular Sciences
|
February 5, 2020
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Anja Wessely, Theresa Steeb, Michael Erdmann, et al.
Cardiovascular and Interventional Radiology
|
October 28, 2025
Initial Experience with Transarterial Chemoembolization in Metastatic Cutaneous Melanoma Patients with Hepatic Progression on Immune Checkpoint Inhibitors
Timo Alexander Auer, Max Schlaak, Gabor Dobos, et al.
Journal of Cancer Research and Clinical Oncology
|
February 10, 2020
Guidelines for uveal melanoma: a critical appraisal of systematically identified guidelines using the AGREE II and AGREE-REX instrument
Theresa Steeb, Kinan M Hayani, Paul Förster, et al.
European Radiology
|
November 29, 2019
Single-slice CT measurements allow for accurate assessment of sarcopenia and body composition
David Zopfs, Sebastian Theurich, Nils Große Hokamp, et al.
Cancers
|
July 9, 2022
Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
Dirk Tomsitz, Max Schlaak, Sarah Zierold, et al.
Langenbeck'S Archives of Surgery
|
January 21, 2023
Oligometastatic disease and visceral resections in advanced malignant melanoma: a propensity-matched analysis
Alexander Urbanski, Julia Minnemann, Cornelia Mauch, et al.
International Journal of Clinical and Experimental Medicine
|
January 8, 2013
(68)Ga-DotaTATE PET-CT followed by Peptide Receptor Radiotherapy in combination with capecitabine in two patients with Merkel Cell Carcinoma
Matthias C Schmidt, Klara Uhrhan, Birgid Markiefka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Multimodal approach predicts relapse upon cessation of immune checkpoint inhibitors in advanced melanoma
Ka-Won Noh, Yuri Tolkach, Doris Helbig, et al.
Page
of 10